Review of industrially recognized polymers and manufacturing processes for amorphous solid dispersion based formulations

References

• Aaron S, Deanna M. 2020. Considerations for the development of amorphous solid dispersions of poorly soluble drugs. CompareNetworks. [accessed 2023 Apr 15]. https://www.americanpharmaceuticalreview.com/.
   Google Scholar
• Abuhelwa AY, Foster DJR, Mudge S, Hayes D, Upton RN. 2015. Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states. Antimicrob Agents Chemother. 59(9):5681–5696. doi: 10.1128/AAC.00973-15.
   PubMed Web of Science ®Google Scholar
• Adhikari A, Polli JE. 2020. Characterization of grades of HPMCAS spray dried dispersions of itraconazole based on supersaturation kinetics and molecular interactions impacting formulation performance. Pharm Res. 37(10):192. doi: 10.1007/s11095-020-02909-6.
   PubMed Web of Science ®Google Scholar
• Akram A, Irfan M, Abualsunun WA, Bukhary DM, Alissa M. 2022. How to improve solubility and dissolution of irbesartan by fabricating ternary solid dispersions: ptimization and in-vitro characterization. Pharmaceutics. 14(11):2264. doi: 10.3390/pharmaceutics14112264.
   PubMed Web of Science ®Google Scholar
• Almeida A, Saerens L, de Beer T, Remon JP, Vervaet C. 2012. Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations. Int J Pharm. 439(1–2):223–229. doi: 10.1016/j.ijpharm.2012.09.037.
   PubMedGoogle Scholar
• Alopaeus JF, Hagesæther E, Tho I. 2019. Micellisation mechanism and behaviour of Soluplus®−Furosemide micelles: preformulation studies of an oral nanocarrier-based system. Pharmaceuticals. 12(1):15. doi: 10.3390/ph12010015.
   Web of Science ®Google Scholar
• Alshahrani SM, Lu W, Park J-B, Morott JT, Alsulays BB, Majumdar S, Langley N, Kolter K, Gryczke A, Repka MA. 2015. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF. AAPS PharmSciTech. 16(4):824–834. doi: 10.1208/s12249-014-0269-6.
   PubMed Web of Science ®Google Scholar
• Alshetaili A, Alshahrani SM, Almutairy BK, Repka MA. 2020. Hot melt extrusion processing parameters optimization. Processes. 8(11):1516. doi: 10.3390/pr8111516.
   Web of Science ®Google Scholar
• Avdeef A, Kansy M. 2022. Trends in PhysChem properties of newly approved drugs over the last six years; predicting solubility of drugs approved in 2021. J Solution Chem. 51(12):1455–1481. doi: 10.1007/s10953-022-01199-3.
   Web of Science ®Google Scholar
• AstraZeneca Pharmaceutical LP [AZP]. 2018. Highlights of prescribing information. Lynparza® (Olaparib) tablets. [accessed 2023 Apr 15]. https://www.accessdata.fda.gov/.
   Google Scholar
• Baghel S, Cathcart H, O’Reilly NJ. 2018. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and 1H NMR. Int J Pharm. 536(1):414–425. doi: 10.1016/j.ijpharm.2017.11.056.
   PubMedGoogle Scholar
• Baghel S, Cathcart H, O'Reilly NJ. 2016. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci. 105(9):2527–2544. doi: 10.1016/j.xphs.2015.10.008.
   PubMed Web of Science ®Google Scholar
• Baghel P, Roy A, Verma S, Satapathy T, Bahadur S. 2020. Amelioration of lipophilic compounds in regards to bioavailability as self-emulsifying drug delivery system (SEDDS). Futur J Pharm Sci. 6(1):21. doi: 10.1186/s43094-020-00042-0.
   Web of Science ®Google Scholar
• Baird JA, Taylor LS. 2012. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Deliv Rev. 64(5):396–421.
   PubMed Web of Science ®Google Scholar
• Baraldo M. 2016. Meltdose tacrolimus pharmacokinetics. Transplant Proc. 48(2):420–423. doi: 10.1016/j.transproceed.2016.02.002.
   PubMed Web of Science ®Google Scholar
• Bhujbal SV, Mitra B, Jain U, Gong Y, Agrawal A, Karki S, Taylor LS, Kumar S, Zhou Q. 2021. Pharmaceutical amorphous solid dispersion: a review of manufacturing strategies. Acta Pharm Sin B. 11(8):2505–2536. doi: 10.1016/j.apsb.2021.05.014.
   PubMed Web of Science ®Google Scholar
• Boersen N, Lee TW-Y, Shen XG, Hui H-W. 2014. A preliminary assessment of the impact of hot-melt extrusion on the physico-mechanical properties of a tablet. Drug Dev Ind Pharm. 40(10):1386–1394. doi: 10.3109/03639045.2013.828216.
   PubMed Web of Science ®Google Scholar
• Boghra RJ, Kothawade PC, Belgamwar VS, Nerkar PP, Tekade AR, Surana SJ. 2011. Solubility, dissolution rate and bioavailability enhancement of irbesartan by solid dispersion technique. Chem Pharm Bull (Tokyo). 59(4):438–441.
   PubMed Web of Science ®Google Scholar
• Browne E, Charifou R, Worku ZA, Babu RP, Healy AM. 2019. Amorphous solid dispersions of ketoprofen and poly-vinyl polymers prepared via electrospraying and spray drying: a comparison of particle characteristics and performance. Int J Pharm. 566:173–184. doi: 10.1016/j.ijpharm.2019.05.062.
   PubMed Web of Science ®Google Scholar
• Browne E, Worku ZA, Healy AM. 2020. Physicochemical properties of poly-vinyl polymers and their influence on ketoprofen amorphous solid dispersion performance: a polymer selection case study. Pharmaceutics. 12(5):433. doi: 10.3390/pharmaceutics12050433.
   PubMed Web of Science ®Google Scholar
• Buch P, Holm P, Thomassen JQ, Scherer D, Branscheid R, Kolb U, Langguth P. 2010. IVIVC for fenofibrate immediate release tablets using solubility and permeability as in vitro predictors for pharmacokinetics. J Pharm Sci. 99(10):4427–4436. doi: 10.1002/jps.22148.
   PubMed Web of Science ®Google Scholar
• Bühler V. 2005. Polyvinylpyrrolidone excipients for pharmaceuticals. Heidelberg: Springer Berlin.
   Google Scholar
• Butreddy A. 2022. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: a review from bench to clinic. Eur J Pharm Biopharm. 177:289–307. doi: 10.1016/j.ejpb.2022.07.010.
   PubMed Web of Science ®Google Scholar
• Butreddy A, Bandari S, Repka MA. 2021. Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development. Eur J Pharm Sci. 158:105655. doi: 10.1016/j.ejps.2020.105655.
   PubMed Web of Science ®Google Scholar
• Catalent. 2021. DisperSol and catalent collaborate to establish KinetiSol® technology manufacturing hub for DisperSol pharmaceutical pipeline. Somerset (NJ): Catalent Inc. [accessed 2023 Apr 15]. https://www.catalent.com/.
   Google Scholar
• Chavan RB, Lodagekar A, Shastri NR. 2018. Determination of precipitation inhibitory potential of polymers from amorphous solid dispersions. Drug Dev Ind Pharm. 44(12):1933–1941. doi: 10.1080/03639045.2018.1503295.
   PubMed Web of Science ®Google Scholar
• Chavan RB, Rathi S, Jyothi VGSS, Shastri NR. 2019. Cellulose based polymers in development of amorphous solid dispersions. Asian J Pharm Sci. 14(3):248–264. doi: 10.1016/j.ajps.2018.09.003.
   PubMed Web of Science ®Google Scholar
• Chavan RB, Thipparaboina R, Kumar D, Shastri NR. 2016. Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth. RSC Adv. 6(81):77569–77576. doi: 10.1039/C6RA19746A.
   Web of Science ®Google Scholar
• Chen H, Pui Y, Liu C, Chen Z, Su C-C, Hageman M, Hussain M, Haskell R, Stefanski K, Foster K, et al. 2018. Moisture-induced amorphous phase separation of amorphous solid dispersions: Molecular mechanism, microstructure, and its impact on dissolution performance. J Pharm Sci. 107(1):317–326. doi: 10.1016/j.xphs.2017.10.028.
   PubMed Web of Science ®Google Scholar
• Chokshi RJ, Shah NH, Sandhu HK, Malick AW, Zia H. 2008. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. J Pharm Sci. 97(6):2286–2298. doi: 10.1002/jps.21174.
   PubMed Web of Science ®Google Scholar
• Craig DQM. 2002. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 231(2):131–144. doi: 10.1016/s0378-5173(01)00891-2.
   PubMed Web of Science ®Google Scholar
• Cui F, Yang M, Jiang Y, Cun D, Lin W, Fan Y, Kawashima Y. 2003. Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method. J Control Release. 91(3):375–384. doi: 10.1016/s0168-3659(03)00275-x.
   PubMed Web of Science ®Google Scholar
• DeBoyace K, Wildfong PLD. 2018. The application of modeling and prediction to the formation and stability of amorphous solid dispersions. J Pharm Sci. 107(1):57–74. doi: 10.1016/j.xphs.2017.03.029.
   PubMed Web of Science ®Google Scholar
• Desai J, Alexander K, Riga A. 2006. Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release. Int J Pharm. 308(1-2):115–123. doi: 10.1016/j.ijpharm.2005.10.034.
   PubMedGoogle Scholar
• Dinunzio JC, Brough C, Hughey JR, Miller DA, Williams RO, McGinity JW. 2010. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing. Eur J Pharm Biopharm. 74(2):340–351. doi: 10.1016/j.ejpb.2009.09.007.
   PubMed Web of Science ®Google Scholar
• Ditzinger F, Price DJ, Ilie A-R, Köhl NJ, Jankovic S, Tsakiridou G, Aleandri S, Kalantzi L, Holm R, Nair A, et al. 2019. Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches - a PEARRL review. J Pharm Pharmacol. 71(4):464–482. doi: 10.1111/jphp.12984.
   PubMed Web of Science ®Google Scholar
• Dobry DE, Settell DM, Baumann JM, Ray RJ, Graham LJ, Beyerinck RA. 2009. A model-based methodology for spray-drying process development. J Pharm Innov. 4(3):133–142. doi: 10.1007/s12247-009-9064-4.
   PubMed Web of Science ®Google Scholar
• Doherty C, York P. 1987. Mechanisms of dissolution of frusemide/PVP solid dispersions. Int J Pharm. 34(3):197–205. doi: 10.1016/0378-5173(87)90180-3.
   Google Scholar
• Dohrn S, Luebbert C, Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G. 2021a. Solvent influence on the phase behavior and glass transition of amorphous solid dispersions. Eur J Pharm Biopharm. 158:132–142. doi: 10.1016/j.ejpb.2020.11.002.
   PubMed Web of Science ®Google Scholar
• Dohrn S, Rawal P, Luebbert C, Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G. 2021b. Predicting process design spaces for spray drying amorphous solid dispersions. Int J Pharm X. 3:100072. doi: 10.1016/j.ijpx.2021.100072.
   PubMedGoogle Scholar
• Ekdahl A, Mudie D, Malewski D, Amidon G, Goodwin A. 2019. Effect of spray-dried particle morphology on mechanical and flow properties of felodipine in PVP VA amorphous solid dispersions. J Pharm Sci. 108(11):3657–3666. doi: 10.1016/j.xphs.2019.08.008.
   PubMed Web of Science ®Google Scholar
• Ellenberger DJ, Miller DA, Williams RO. 2018. Expanding the application and formulation space of amorphous solid dispersions with KinetiSol®: a Review. AAPS PharmSciTech. 19(5):1933–1956. doi: 10.1208/s12249-018-1007-2.
   PubMed Web of Science ®Google Scholar
• Fan N, Li J, Li J. 2021. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by udragit E100. J Pharm Pharmacol. 73(2):185–192. doi: 10.1093/jpp/rgaa012.
   PubMed Web of Science ®Google Scholar
• Ferreira MP, Martins JP, Hirvonen J, Santos HA. 2020. Spray-drying for the formulation of oral drug delivery systems. In: Martins JP, Santos H, editors. Nanotechnology for oral drug delivery. Academic Press; p. 253–284. https://doi.org/10.1016/B978-0-12-818038-9.00007-7
   Google Scholar
• Franco A, Más-Serrano P, Balibrea N, Rodriguez D, Javaloyes A, Díaz M, Gascón I, Ramon-Lopez A, Perez-Contreras J, Selva J, et al. 2019. Envarsus, a novelty for transplant nephrologists: observational retrospective study. Nefrologia (Engl Ed). 39(5):506–512. doi: 10.1016/j.nefro.2018.11.009.
   PubMedGoogle Scholar
• Friesen DT, Shanker R, Crew M, Smithey DT, Curatolo WJ, Nightingale JAS. 2008. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol Pharm. 5(6):1003–1019. doi: 10.1021/mp8000793.
   PubMed Web of Science ®Google Scholar
• Furuishi T, Sato-Hata N, Fukuzawa K, Yonemochi E. 2023. Characterization of co-amorphous carvedilol–maleic acid system prepared by solvent evaporation. Pharm Dev Technol. 28(3-4):309–317. doi: 10.1080/10837450.2023.2194406.
   PubMedGoogle Scholar
• Gala UH, Miller DA, Williams RO. 2020. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochim Biophys Acta Rev Cancer. 1873(1):188319. doi: 10.1016/j.bbcan.2019.188319.
   PubMed Web of Science ®Google Scholar
• Goddeeris C, Willems T, van den Mooter G. 2008. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781. Eur J Pharm Sci. 34(4–5):293–302. doi: 10.1016/j.ejps.2008.05.005.
   PubMed Web of Science ®Google Scholar
• Gottschalk T, Grönniger B, Ludwig E, Wolbert F, Feuerbach T, Sadowski G, Thommes M. 2022. Influence of process temperature and residence time on the manufacturing of amorphous solid dispersions in hot melt extrusion. Pharm Dev Technol. 27(3):313–318. doi: 10.1080/10837450.2022.2051549.
   PubMed Web of Science ®Google Scholar
• Gupta SS, Solanki N, Serajuddin ATM. 2016. Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion, IV: affinisolTM HPMC HME polymers. AAPS PharmSciTech. 17(1):148–157. doi: 10.1208/s12249-015-0426-6.
   PubMed Web of Science ®Google Scholar
• Han SD, Jung SW, Jang SW, Jung HJ, Son M, Kim BM, Kang MJ. 2015. Preparation of solid dispersion of dronedarone hydrochloride with Soluplus(®) by hot melt extrusion technique for enhanced drug release. Chem Pharm Bull (Tokyo). 63(4):295–299. doi: 10.1248/cpb.c14-00725.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Parks M. 2000. What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res. 17(4):397–404. doi: 10.1023/a:1007516718048.
   PubMed Web of Science ®Google Scholar
• Harmon P, Galipeau K, Xu W, Brown C, Wuelfing WP. 2016. Mechanism of dissolution-induced nanoparticle formation from a copovidone-based amorphous solid dispersion. Mol Pharm. 13(5):1467–1481. doi: 10.1021/acs.molpharmaceut.5b00863.
   PubMedGoogle Scholar
• Hörmann TR, Jäger N, Funke A, Mürb R-K, Khinast JG, Paudel A. 2018. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization. Int J Pharm. 553(1–2):408–421. doi: 10.1016/j.ijpharm.2018.10.035.
   PubMedGoogle Scholar
• Huang W, Mandal T, Larson RG. 2017. Computational modeling of hydroxypropyl-methylcellulose acetate succinate (HPMCAS) and phenytoin interactions: A systematic coarse-graining approach. Mol Pharm. 14(3):733–745. doi: 10.1021/acs.molpharmaceut.6b01013.
   PubMedGoogle Scholar
• Huang J, Wigent RJ, Schwartz JB. 2006. Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition. Drug Dev Ind Pharm. 32(10):1185–1197. doi: 10.1080/03639040600832827.
   PubMed Web of Science ®Google Scholar
• Hughey JR, Keen JM, Miller DA, Kolter K, Langley N, McGinity JW. 2013. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. Eur J Pharm Sci. 48(4–5):758–766. doi: 10.1016/j.ejps.2013.01.004.
   PubMed Web of Science ®Google Scholar
• Inam S, Irfan M, Lali NUA, Khalid Syed H, Asghar S, Khan IU, Khan S-U-D, Iqbal MS, Zaheer I, Khames A, et al. 2022. Development and characterization of Eudragit® EPO-based solid dispersion of rosuvastatin calcium to foresee the impact on solubility, dissolution and antihyperlipidemic activity. Pharmaceuticals. 15(4):492. doi: 10.3390/ph15040492.
   Web of Science ®Google Scholar
• Indulkar AS, Lou X, Zhang GGZ, Taylor LS. 2019. Insights into the dissolution mechanism of ritonavir-copovidone amorphous solid dispersions: Importance of congruent release for enhanced performance. Mol Pharm. 16(3):1327–1339. doi: 10.1021/acs.molpharmaceut.8b01261.
   PubMedGoogle Scholar
• Iyer R, Hegde S, Zhang Y-E, Dinunzio J, Singhal D, Malick A, Amidon G. 2013. The impact of hot melt extrusion and spray drying on mechanical properties and tableting indices of materials used in pharmaceutical development. J Pharm Sci. 102(10):3604–3613. doi: 10.1002/jps.23661.
   PubMed Web of Science ®Google Scholar
• Iyer R, Jovanovska VP, Berginc K, Jaklič M, Fabiani F, Harlacher C, Huzjak T, Sanchez-Felix MV. 2021. Amorphous solid dispersions (ASDs): the influence of material properties, manufacturing processes and analytical technologies in drug product development. Pharmaceutics. 13(10):1682. doi: 10.3390/pharmaceutics13101682.
   PubMed Web of Science ®Google Scholar
• Jermain SV, Miller D, Spangenberg A, Lu X, Moon C, Su Y, Williams RO. 2019. Homogeneity of amorphous solid dispersions - an example with KinetiSol®. Drug Dev Ind Pharm. 45(5):724–735. doi: 10.1080/03639045.2019.1569037.
   PubMed Web of Science ®Google Scholar
• Jog R, Gokhale R, Burgess DJ. 2016. Solid state drug-polymer miscibility studies using the model drug ABT-102. Int J Pharm. 509(1–2):285–295. doi: 10.1016/j.ijpharm.2016.05.068.
   PubMedGoogle Scholar
• Jung JY, Yoo SD, Lee SH, Kim KH, Yoon DS, Lee KH. 1999. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm. 187(2):209–218. doi: 10.1016/s0378-5173(99)00191-x.
   PubMedGoogle Scholar
• Kallakunta VR, Sarabu S, Bandari S, Batra A, Bi V, Durig T, Repka MA. 2020. Stable amorphous solid dispersions of fenofibrate using hot melt extrusion technology: effect of formulation and process parameters for a low glass transition temperature drug. J Drug Deliv Sci Technol. 58:101395. doi: 10.1016/j.jddst.2019.101395.
   PubMed Web of Science ®Google Scholar
• Kamar N, Cassuto E, Piotti G, Govoni M, Ciurlia G, Geraci S, Poli G, Nicolini G, Mariat C, Essig M, et al. 2019. Pharmacokinetics of prolonged-release once-daily formulations of tacrolimus in de novo kidney transplant recipients: a randomized, parallel-group, open-Label, multicenter study. Adv Ther. 36(2):462–477. doi: 10.1007/s12325-018-0855-1.
   PubMed Web of Science ®Google Scholar
• Kapourani A, Eleftheriadou K, Kontogiannopoulos KN, Barmpalexis P. 2021. Evaluation of rivaroxaban amorphous solid dispersions physical stability via molecular mobility studies and molecular simulations. Eur J Pharm Sci. 157:105642. doi: 10.1016/j.ejps.2020.105642.
   PubMed Web of Science ®Google Scholar
• Kapourani A, Vardaka E, Katopodis K, Kachrimanis K, Barmpalexis P. 2019. Rivaroxaban polymeric amorphous solid dispersions: Moisture-induced thermodynamic phase behavior and intermolecular interactions. Eur J Pharm Biopharm. 145:98–112. doi: 10.1016/j.ejpb.2019.10.010.
   PubMed Web of Science ®Google Scholar
• Kararli TT, Hurlbut JB, Needham TE. 1990. Glass–rubber transitions of cellulosic polymers by dynamic mechanical analysis. J Pharm Sci. 79(9):845–848. doi: 10.1002/jps.2600790922.
   PubMed Web of Science ®Google Scholar
• Kaushal AM, Gupta P, Bansal AK. 2004. Amorphous drug delivery systems: molecular aspects, design, and performance. Crit Rev Ther Drug Carrier Syst. 21(3):133–193. doi: 10.1615/critrevtherdrugcarriersyst.v21.i3.10.
   PubMedGoogle Scholar
• Kaushik R, Budhwar V, Kaushik D. 2020. An overview on recent patents and technologies on solid dispersion. Recent Pat Drug Deliv Formul. 14(1):63–74. doi: 10.2174/1872211314666200117094406.
   PubMedGoogle Scholar
• Keen JM, Martin C, Machado A, Sandhu H, McGinity JW, DiNunzio JC. 2014. Investigation of process temperature and screw speed on properties of a pharmaceutical solid dispersion using corotating and counter-rotating twin-screw extruders. J Pharm Pharmacol. 66(2):204–217. doi: 10.1111/jphp.12106.
   PubMed Web of Science ®Google Scholar
• Kim KT, Lee JY, Lee MY, Song CK, Choi JH, Kim DD. 2011. Solid dispersions as a drug delivery system. J Pharm Investig. 41(3):125–142. doi: 10.4333/KPS.2011.41.3.125.
   Google Scholar
• Kini A, Patel SB. 2017. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat. Pharm Dev Technol. 22(1):45–57. doi: 10.3109/10837450.2016.1138130.
   PubMed Web of Science ®Google Scholar
• Knopp MM, Nguyen JH, Becker C, Francke NM, Jørgensen EB, Holm P, Holm R, Mu H, Rades T, Langguth P. 2016. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions. Eur J Pharm Biopharm. 101:145–151. doi: 10.1016/j.ejpb.2016.02.007.
   PubMed Web of Science ®Google Scholar
• Knopp MM, Olesen NE, Holm P, Langguth P, Holm R, Rades T. 2015. Influence of polymer molecular weight on drug-polymer solubility: A comparison between experimentally determined solubility in PVP and prediction derived from solubility in monomer. J Pharm Sci. 104(9):2905–2912. doi: 10.1002/jps.24410.
   PubMed Web of Science ®Google Scholar
• Kolter K, Karl M, Gryczke A, Se B. 2012. Hot-melt extrusion with BASF pharma polymers extrusion compendium. 2nd revised ed. Ludwigshafen: BASF SE.
   Google Scholar
• Konno H, Handa T, Alonzo DE, Taylor LS. 2008. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm. 70(2):493–499. doi: 10.1016/j.ejpb.2008.05.023.
   PubMed Web of Science ®Google Scholar
• Konno H, Taylor LS. 2006. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci. 95(12):2692–2705. doi: 10.1002/jps.20697.
   PubMed Web of Science ®Google Scholar
• Krummnow A, Danzer A, Voges K, Dohrn S, Kyeremateng SO, Degenhardt M, Sadowski G. 2022. Explaining the release mechanism of ritonavir/PVPVA amorphous solid dispersions. Pharmaceutics. 14(9):1904. doi: 10.3390/pharmaceutics14091904.
   PubMed Web of Science ®Google Scholar
• Kurakula M, Rao GSNK. 2020. Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition. J Drug Deliv Sci Technol. 60:102046. doi: 10.1016/j.jddst.2020.102046.
   PubMed Web of Science ®Google Scholar
• Kushida I, Gotoda M. 2013. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method. Drug Dev Ind Pharm. 39(10):1582–1588. doi: 10.3109/03639045.2012.679279.
   PubMed Web of Science ®Google Scholar
• Kyeremateng SO, Voges K, Dohrn S, Sobich E, Lander U, Weber S, Gessner D, Evans RC, Degenhardt M. 2022. A hot-melt extrusion risk assessment classification system for amorphous solid dispersion formulation development. Pharmaceutics. 14(5):1044. doi: 10.3390/pharmaceutics14051044.
   PubMed Web of Science ®Google Scholar
• Lakshman D, Chegireddy M, Hanegave GK, Sree KN, Kumar N, Lewis SA, Dengale SJ. 2020. Investigation of drug-polymer miscibility, biorelevant dissolution, and bioavailability improvement of dolutegravir-polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer solid dispersions. Eur J Pharm Sci. 142:105137. doi: 10.1016/j.ejps.2019.105137.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 50(1):47–60. doi: 10.1016/s0939-6411(00)00076-x.
   PubMed Web of Science ®Google Scholar
• [LCP] CSE no. 04. 2008. Life cycle pharma launches its first product in the U.S. 2008 Feb 21. Fierce Biotech. [accessed 2023 Apr 15]. https://www.fiercebiotech.com/.
   Google Scholar
• Lin X, Hu Y, Liu L, Su L, Li N, Yu J, Tang B, Yang Z. 2018. Physical stability of amorphous solid dispersions: a physicochemical perspective with thermodynamic, kinetic and environmental aspects. Pharm Res. 35(6):125. doi: 10.1007/s11095-018-2408-3.
   PubMed Web of Science ®Google Scholar
• Lindfors L, Forssén S, Westergren J, Olsson U. 2008. Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interface Sci. 325(2):404–413. doi: 10.1016/j.jcis.2008.05.034.
   PubMed Web of Science ®Google Scholar
• Linn M, Collnot E-M, Djuric D, Hempel K, Fabian E, Kolter K, Lehr C-M. 2012. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci. 45(3):336–343. doi: 10.1016/j.ejps.2011.11.025.
   PubMed Web of Science ®Google Scholar
• Liu P, Zhou JY, Chang JH, Liu XG, Xue HF, Wang RX, Li ZS, Li CS, Wang J, Liu CZ. 2020. Soluplus-mediated diosgenin amorphous solid dispersion with high solubility and high stability: development, characterization and oral bioavailability. Drug Des Devel Ther. 14:2959–2975. doi: 10.2147/DDDT.S253405.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. 2010. Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol. 62(11):1607–1621. doi: 10.1111/j.2042-7158.2010.01030.x.
   PubMed Web of Science ®Google Scholar
• Lu J, Cuellar K, Hammer NI, Jo S, Gryczke A, Kolter K, Langley N, Repka MA. 2016a. Solid-state characterization of felodipine-soluplus amorphous solid dispersions. Drug Dev Ind Pharm. 42(3):485–496. doi: 10.3109/03639045.2015.1104347.
   PubMed Web of Science ®Google Scholar
• Luebbert C, Huxoll F, Sadowski G. 2017. Amorphous-amorphous phase separation in API/polymer formulations. Molecules. 22(2):296. doi: 10.3390/molecules22020296.
   PubMed Web of Science ®Google Scholar
• Lu Z, Yang Y, Covington R-A, Bi YV, Dürig T, Ilies MA, Fassihi R. 2016b. Supersaturated controlled release matrix using amorphous dispersions of glipizide. Int J Pharm. 511(2):957–968. doi: 10.1016/j.ijpharm.2016.07.072.
   PubMedGoogle Scholar
• Matsumoto T, Zografi G. 1999. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res. 16(11):1722–1728. doi: 10.1023/a:1018906132279.
   PubMed Web of Science ®Google Scholar
• Mayne Pharma. 2023. Mayne Pharma: SUBA® bioavailability technology. [accessed 2023 Apr 15]. https://www.maynepharma.com/.
   Google Scholar
• Medarević D, Djuriš J, Barmpalexis P, Kachrimanis K, Ibrić S. 2019. Analytical and computational methods for the estimation of drug-polymer solubility and miscibility in solid dispersions development. Pharmaceutics. 11(8):372. doi: 10.3390/pharmaceutics11080372.
   PubMed Web of Science ®Google Scholar
• Meng F, Dave V, Chauhan H. 2015. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems. Eur J Pharm Sci. 77:106–111. doi: 10.1016/j.ejps.2015.05.018.
   PubMed Web of Science ®Google Scholar
• Miller DA, Keen JM. 2014. KinetiSol®-based amorphous solid dispersions. In: Shah N, Sandhu H, Choi DS, Chokshi H, Malick AW, editors. Amorphous solid dispersions. New York (NY): Springer; p. 567–577.
   Google Scholar
• Milne M, Liebenberg W, Aucamp M. 2015. The stabilization of amorphous zopiclone in an amorphous solid dispersion. AAPS PharmSciTech. 16(5):1190–1202. doi: 10.1208/s12249-015-0302-4.
   PubMed Web of Science ®Google Scholar
• Mohapatra S, Samanta S, Kothari K, Mistry P, Suryanarayanan R. 2017. Effect of polymer molecular weight on the crystallization behavior of indomethacin amorphous solid dispersions. Cryst Growth Des. 17(6):3142–3150. doi: 10.1021/acs.cgd.7b00096.
   Web of Science ®Google Scholar
• Moseson DE, Parker AS, Beaudoin SP, Taylor LS. 2020. Amorphous solid dispersions containing residual crystallinity: influence of seed properties and polymer adsorption on dissolution performance. Eur J Pharm Sci. 146:105276. doi: 10.1016/j.ejps.2020.105276.
   PubMed Web of Science ®Google Scholar
• Mudge SJ, Hayes D, Lukas S; Inventors; Mayne Pharma International Pty. Ltd., Assignee. 2018. Itraconazole compositions and dosage forms, and methods of using the same. United States patent US9,272,046.
   Google Scholar
• Nair AR, Lakshman YD, Anand VSK, Sree KSN, Bhat K, Dengale SJ. 2020. Overview of extensively employed polymeric carriers in solid dispersion technology. AAPS PharmSciTech. 21(8):309. doi: 10.1208/s12249-020-01849-z.
   PubMed Web of Science ®Google Scholar
• Nespi M, Kuhn R, Yen C-W, Lubach JW, Leung D. 2021. Optimization of spray-drying parameters for formulation development at preclinical scale. AAPS PharmSciTech. 23(1):28. doi: 10.1208/s12249-021-02160-1.
   PubMed Web of Science ®Google Scholar
• Nogami H, Nagai T, Kondo A. 1970. Dissolution kinetics of polyvinylpyrrolidone of various molecular weights. Chem Pharm Bull. 18(11):2290–2296. doi: 10.1248/cpb.18.2290.
   Web of Science ®Google Scholar
• Ohara T, Kitamura S, Kitagawa T, Terada K. 2005. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. Int J Pharm. 302(1-2):95–102. doi: 10.1016/j.ijpharm.2005.06.019.
   PubMedGoogle Scholar
• Okonogi S, Oguchi T, Yonemochi E, Puttipipatkhachorn S, Yamamoto K. 1997. Improved dissolution of ofloxacin via solid dispersion. Int J Pharm. 156(2):175–180. doi: 10.1016/S0378-5173(97)00196-8.
   Web of Science ®Google Scholar
• Oliveri D, Müller RM. 2022. BASF Pharma solutions excipient accepted into FDA pilot program for novel excipients. New Jersey (US): BASF. [accessed 2023 Apr 15]. https://www.basf.com/.
   Google Scholar
• Pandi P, Bulusu R, Kommineni N, Khan W, Singh M. 2020. Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. Int J Pharm. 586:119560. doi: 10.1016/j.ijpharm.2020.119560.
   PubMed Web of Science ®Google Scholar
• Patel DD, Anderson BD. 2015. Adsorption of polyvinylpyrrolidone and its impact on maintenance of aqueous supersaturation of indomethacin via crystal growth inhibition. J Pharm Sci. 104(9):2923–2933. doi: 10.1002/jps.24493.
   PubMed Web of Science ®Google Scholar
• Patel BB, Patel JK, Chakraborty S, Shukla D. 2015. Revealing facts behind spray dried solid dispersion technology used for solubility enhancement. Saudi Pharm J. 23(4):352–365. doi: 10.1016/j.jsps.2013.12.013.
   PubMed Web of Science ®Google Scholar
• Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T. 2007. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm. 336(1):22–34. doi: 10.1016/j.ijpharm.2006.11.030.
   PubMed Web of Science ®Google Scholar
• Patterson JE, James MB, Forster AH, Rades T. 2008. Melt extrusion and spray drying of carbamazepine and dipyridamole with polyvinylpyrrolidone/vinyl acetate copolymers. Drug Dev Ind Pharm. 34(1):95–106. doi: 10.1080/03639040701484627.
   PubMed Web of Science ®Google Scholar
• Paudel A, Worku ZA, Meeus J, Guns S, van den Mooter G. 2013. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm. 453(1):253–284. doi: 10.1016/j.ijpharm.2012.07.015.
   PubMed Web of Science ®Google Scholar
• Penumetcha SS, Gutta LN, Dhanala H, Yamili S, Challa S, Rudraraju S, Rudraraju S, Rudraraju V. 2016. Hot melt extruded aprepitant-soluplus solid dispersion: preformulation considerations, stability and in vitro study. Drug Dev Ind Pharm. 42(10):1609–1620. doi: 10.3109/03639045.2016.1160105.
   PubMed Web of Science ®Google Scholar
• Per Holm V; Inventors; Lifecycle Pharma A/S, Assignee. 2011. Solid dispersions comprising Tacrolimus. United States patent US7994214.
   Google Scholar
• Pignatello R, Corsaro R, Bonaccorso A, Zingale E, Carbone C, Musumeci T. 2022. Soluplus® polymeric nanomicelles improve solubility of BCS-class II drugs. Drug Deliv Transl Res. 12(8):1991–2006. doi: 10.1007/s13346-022-01182-x.
   PubMed Web of Science ®Google Scholar
• Pinto JMO, Rengifo AFC, Mendes C, Leão AF, Parize AL, Stulzer HK. 2020. Understanding the interaction between Soluplus® and biorelevant media components. Colloids Surf B Biointerfaces. 187:110673. doi: 10.1016/j.colsurfb.2019.110673.
   PubMed Web of Science ®Google Scholar
• Pisay M, Yarlagadda DL, Vullendula SKA, Bhat K, Kunnatur Balasundara K, Mutalik S. 2023. Effervescence-induced amorphous solid dispersions with improved drug solubility and dissolution. Pharm Dev Technol. 28(2):176–189. doi: 10.1080/10837450.2023.2172039.
   PubMed Web of Science ®Google Scholar
• Pu Y, Menger R, Tong Z, Gaebele T. 2022. Development of an enhanced formulation to minimize pharmacokinetic variabilities of a weakly basic drug compound. Pharm Dev Technol. 27(4):406–413. doi: 10.1080/10837450.2022.2070206.
   PubMed Web of Science ®Google Scholar
• Punčochová K, Ewing A v, Gajdošová M, Sarvašová N, Kazarian SG, Beránek J, Štěpánek F. 2015. Identifying the mechanisms of drug release from amorphous solid dispersions using MRI and ATR-FTIR spectroscopic imaging. Int J Pharm. 483(1–2):256–267. doi: 10.1016/j.ijpharm.2015.02.035.
   PubMedGoogle Scholar
• Que C, Qi Q, Zemlyanov DY, Mo H, Deac A, Zeller M, Indulkar AS, Gao Y, Zhang GGZ, Taylor LS. 2020. Evidence for halogen bonding in amorphous solid dispersions. Cryst Growth Des. 20(5):3224–3235. doi: 10.1021/acs.cgd.0c00073.
   Web of Science ®Google Scholar
• Rahman M, Coelho A, Tarabokija J, Ahmad S, Radgman K, Bilgili E. 2020. Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions. Eur J Pharm Sci. 150:105354. doi: 10.1016/j.ejps.2020.105354.
   PubMed Web of Science ®Google Scholar
• Rauseo AM, Mazi P, Lewis P, Burnett B, Mudge S, Spec A. 2021. Bioavailability of single-dose SUBA-itraconazole compared to conventional itraconazole under fasted and fed conditions. Antimicrob Agents Chemother. 65(8):e0013421. doi: 10.1128/AAC.00134-21.
   PubMed Web of Science ®Google Scholar
• Ré MI. 2006. Formulating drug delivery systems by spray drying. Drying Technol. 24(4):433–446. doi: 10.1080/07373930600611877.
   Web of Science ®Google Scholar
• Rumondor ACF, Marsac PJ, Stanford LA, Taylor LS. 2009. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol Pharm. 6(5):1492–1505. doi: 10.1021/mp900050c.
   PubMed Web of Science ®Google Scholar
• Saha SK, Joshi A, Singh R, Jana S, Dubey K. 2023. An investigation into solubility and dissolution improvement of alectinib hydrochloride as a third-generation amorphous solid dispersion. J Drug Deliv Sci Technol. 81:104259. doi: 10.1016/j.jddst.2023.104259.
   Web of Science ®Google Scholar
• Sahoo NG, Abbas A, Judeh Z, Li CM, Yuen K-H. 2009. Solubility enhancement of a poorly water-soluble anti-malarial drug: experimental design and use of a modified multifluid nozzle pilot spray drier. J Pharm Sci. 98(1):281–296. doi: 10.1002/jps.21399.
   PubMed Web of Science ®Google Scholar
• Sakurai A, Sakai T, Sako K, Maitani Y. 2012. Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study. Chem Pharm Bull (Tokyo). 60(4):459–464. doi: 10.1248/cpb.60.459.
   PubMed Web of Science ®Google Scholar
• Sarpal K, Delaney S, Zhang GGZ, Munson EJ. 2019. Phase behavior of amorphous solid dispersions of felodipine: homogeneity and drug-polymer interactions. Mol Pharm. 16(12):4836–4851. doi: 10.1021/acs.molpharmaceut.9b00731.
   PubMedGoogle Scholar
• Sarpal K, Munson EJ. 2021. Amorphous solid dispersions of felodipine and nifedipine with Soluplus®: Drug-polymer miscibility and intermolecular interactions. J Pharm Sci. 110(4):1457–1469. doi: 10.1016/j.xphs.2020.12.022.
   PubMed Web of Science ®Google Scholar
• Shamma RN, Basha M. 2013. Soluplus®: a novel polymeric solubilizer for optimization of carvedilol solid dispersions: formulation design and effect of method of preparation. Powder Technol. 237:406–414. doi: 10.1016/j.powtec.2012.12.038.
   Web of Science ®Google Scholar
• Sharma KS, Sahoo J, Agrawal S, Kumari A. 2019. Solid dispersions: a technology for improving bioavailability. JAPLR. 8(4):127–133. doi: 10.15406/japlr.2019.08.00326.
   Google Scholar
• Shi N-Q, Lai H-W, Zhang Y, Feng B, Xiao X, Zhang H-M, Li Z-Q, Qi X-R. 2018. On the inherent properties of soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology. Pharm Dev Technol. 23(6):573–586. doi: 10.1080/10837450.2016.1256409.
   PubMed Web of Science ®Google Scholar
• Shi X, Xu T, Huang W, Fan B, Sheng X. 2019. Stability and bioavailability enhancement of telmisartan ternary solid dispersions: the synergistic effect of polymers and drug-polymer(s) interactions. AAPS PharmSciTech. 20(4):143. doi: 10.1208/s12249-019-1358-3.
   PubMed Web of Science ®Google Scholar
• Simões MF, Pinto RMA, Simões S. 2019. Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug application. Drug Discov Today. 24(9):1749–1768. doi: 10.1016/j.drudis.2019.05.013.
   PubMed Web of Science ®Google Scholar
• Singh A, Bharati A, Frederiks P, Verkinderen O, Goderis B, Cardinaels R, Moldenaers P, van Humbeeck J, van den Mooter G. 2016. Effect of compression on the molecular arrangement of itraconazole-soluplus solid dispersions: induction of liquid Crystals or Exacerbation of Phase Separation? Mol Pharm. 13(6):1879–1893. doi: 10.1021/acs.molpharmaceut.6b00046.
   PubMedGoogle Scholar
• Singh A, van den Mooter G. 2016. Spray drying formulation of amorphous solid dispersions. Adv Drug Deliv Rev. 100:27–50. doi: 10.1016/j.addr.2015.12.010.
   PubMed Web of Science ®Google Scholar
• Slámová M, Školáková T, Školáková A, Patera J, Zámostný P. 2020. Preparation of solid dispersions with respect to the dissolution rate of active substance. J Drug Deliv Sci Technol. 56:101518. doi: 10.1016/j.jddst.2020.101518.
   Web of Science ®Google Scholar
• Smeets A, Koekoekx R, Clasen C, van den Mooter G. 2018. Amorphous solid dispersions of darunavir: comparison between spray drying and electrospraying. Eur J Pharm Biopharm. 130:96–107. doi: 10.1016/j.ejpb.2018.06.021.
   PubMed Web of Science ®Google Scholar
• Solanki NG, Lam K, Tahsin M, Gumaste SG, Shah AV, Serajuddin ATM. 2019. Effects of surfactants on itraconazole-HPMCAS solid dispersion prepared by hot-melt extrusion I: miscibility and drug release. J Pharm Sci. 108(4):1453–1465. doi: 10.1016/j.xphs.2018.10.058.
   PubMed Web of Science ®Google Scholar
• Song B, Wang J, Lu S, Shan L. 2020. Andrographolide solid dispersions formulated by Soluplus to enhance interface wetting, dissolution, and absorption. J Appl Polym Sci. 137(6):48354. doi: 10.1002/app.48354.
   Web of Science ®Google Scholar
• Sotthivirat S, McKelvey C, Moser J, Rege B, Xu W, Zhang D. 2013. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364. Int J Pharm. 452(1-2):73–81. doi: 10.1016/j.ijpharm.2013.04.037.
   PubMedGoogle Scholar
• Strojewski D, Krupa A. 2022. Kollidon® VA 64 and Soluplus® as modern polymeric carriers for amorphous solid dispersions. Polim Med. 52(1):19–29. doi: 10.17219/pim/150267.
   PubMedGoogle Scholar
• Sugihara H, Taylor LS. 2018. Evaluation of pazopanib phase behavior following pH-induced supersaturation. Mol Pharm. 15(4):1690–1699. doi: 10.1021/acs.molpharmaceut.8b00081.
   PubMedGoogle Scholar
• Sui X, Chu Y, Zhang J, Zhang H, Wang H, Liu T, Han C. 2020. The effect of PVP molecular weight on dissolution behavior and physicochemical characterization of glycyrrhetinic acid solid dispersions. Adv Polym Technol. 2020:1–13. doi: 10.1155/2020/8859658.
   Web of Science ®Google Scholar
• Tambe S, Jain D, Meruva SK, Rongala G, Juluri A, Nihalani G, Mamidi HK, Nukala PK, Bolla PK. 2022. Recent advances in amorphous solid dispersions: preformulation, formulation strategies, technological advancements and characterization. Pharmaceutics. 14(10):2203. doi: 10.3390/pharmaceutics14102203.
   PubMed Web of Science ®Google Scholar
• Tan DK, Davis DA, Miller DA, Williams RO, Nokhodchi A. 2020. Innovations in thermal processing: hot-melt extrusion and KinetiSol® dispersing. AAPS PharmSciTech. 21(8):312. doi: 10.1208/s12249-020-01854-2.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. 1997. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res. 14(12):1691–1698. doi: 10.1023/a:1012167410376.
   PubMed Web of Science ®Google Scholar
• Temtem M. 2018. The coming of age of amorphous solid dispersions. Pharma’s Almanac. [accessed 2023 Apr 15]. https://www.pharmasalmanac.com/articles/the-coming-of-age-of-amorphous-solid-dispersions.
   Google Scholar
• Thiry J, Krier F, Evrard B. 2015. A review of pharmaceutical extrusion: critical process parameters and scaling-up. Int J Pharm. 479(1):227–240. doi: 10.1016/j.ijpharm.2014.12.036.
   PubMed Web of Science ®Google Scholar
• Thybo P, Hovgaard L, Lindeløv JS, Brask A, Andersen SK. 2008. Scaling up the spray drying process from pilot to production scale using an atomized droplet size criterion. Pharm Res. 25(7):1610–1620. doi: 10.1007/s11095-008-9565-8.
   PubMed Web of Science ®Google Scholar
• Tiwari RV, Patil H, Repka MA. 2016. Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century. Expert Opin Drug Deliv. 13(3):451–464. doi: 10.1517/17425247.2016.1126246.
   PubMed Web of Science ®Google Scholar
• Tolsura. 2023. Advanced antifungal delivery technology. Mayne Pharma. [accessed 2023 Apr 15]. https://tolsura.com/about-tolsura/.
   Google Scholar
• Tran P, Pyo YC, Kim DH, Lee SE, Kim JK, Park JS. 2019. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 11(3):132. doi: 10.3390/pharmaceutics11030132.
   PubMed Web of Science ®Google Scholar
• Tran TTD, Tran PHL. 2020. Molecular interactions in solid dispersions of poorly water-soluble drugs. Pharmaceutics. 12(8):745. doi: 10.3390/pharmaceutics12080745.
   PubMed Web of Science ®Google Scholar
• Trasi NS, Purohit HS, Taylor LS. 2017. Evaluation of the crystallization tendency of commercially available amorphous tacrolimus formulations exposed to different stress conditions. Pharm Res. 34(10):2142–2155. doi: 10.1007/s11095-017-2221-4.
   PubMed Web of Science ®Google Scholar
• Tremblay S, Nigro V, Weinberg J, Woodle ES, Alloway RR. 2017. A steady-state head-to-head pharmacokinetic comparison of All FK-506 (tacrolimus) formulations (ASTCOFF): an open-label, prospective, randomized, two-arm, three-period crossover study. Am J Transplant. 17(2):432–442. doi: 10.1111/ajt.13935.
   PubMed Web of Science ®Google Scholar
• Tsinman O, Tsinman K, Ali S. 2015. EXCIPIENT UPDATE – Soluplus®: An understanding of supersaturation from amorphous solid dispersions. Drug Development & Delivery; [accessed 2023 Apr 15]. https://drug-dev.com/.
   Google Scholar
• Turner DT, Schwartz A. 1985. The glass transition temperature of poly(N-vinyl pyrrolidone) by differential scanning calorimetry. Polymer. 26(5):757–762. doi: 10.1016/0032-3861(85)90114-4.
   Web of Science ®Google Scholar
• Ueda K, Okada H, Zhao Z, Higashi K, Moribe K. 2020. Application of solid-state 13C relaxation time to prediction of the recrystallization inhibition strength of polymers on amorphous felodipine at low polymer loading. Int J Pharm. 581:119300. doi: 10.1016/j.ijpharm.2020.119300.
   PubMedGoogle Scholar
• Ueno Y, Yonemochi E, Tozuka Y, Yamamura S, Oguchi T, Yamamoto K. 1998. Characterization of amorphous ursodeoxycholic acid prepared by spray-drying. J Pharm Pharmacol. 50(11):1213–1219. doi: 10.1111/j.2042-7158.1998.tb03336.x.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Marques S, das Neves J, Sarmento B. 2016. Amorphous solid dispersions: rational selection of a manufacturing process. Adv Drug Deliv Rev. 100:85–101. doi: 10.1016/j.addr.2016.01.012.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 12(23-24):1068–1075. doi: 10.1016/j.drudis.2007.09.005.
   PubMed Web of Science ®Google Scholar
• Vinarov Z, Abrahamsson B, Artursson P, Batchelor H, Berben P, Bernkop-Schnürch A, Butler J, Ceulemans J, Davies N, Dupont D, et al. 2021. Current challenges and future perspectives in oral absorption research: an opinion of the UNGAP network. Adv Drug Deliv Rev. 171:289–331.,. doi: 10.1016/j.addr.2021.02.001.
   PubMed Web of Science ®Google Scholar
• Vo CLN, Park C, Lee BJ. 2013. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm. 85(3 Pt B):799–813. doi: 10.1016/j.ejpb.2013.09.007.
   PubMed Web of Science ®Google Scholar
• von Einsiedel J, Thölking G, Wilms C, Vorona E, Bokemeyer A, Schmidt HH, Kabar I, Hüsing-Kabar A. 2020. Conversion from standard-release tacrolimus to MeltDose® tacrolimus (LCPT) improves renal function after liver transplantation. JCM. 9(6):1654. doi: 10.3390/jcm9061654.
   Google Scholar
• Wang S, Langrish T. 2009. A review of process simulations and the use of additives in spray drying. Food Res Int. 42(1):13–25. doi: 10.1016/j.foodres.2008.09.006.
   Web of Science ®Google Scholar
• Wang A, Lu Y, Zhu R, Li S, Ma X. 2009. Effect of process parameters on the performance of spray dried hydroxyapatite microspheres. Powder Technol. 191(1-2):1–6. doi: 10.1016/j.powtec.2008.10.020.
   Web of Science ®Google Scholar
• Wegiel LA, Zhao Y, Mauer LJ, Edgar KJ, Taylor LS. 2014. Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability. Pharm Dev Technol. 19(8):976–986. doi: 10.3109/10837450.2013.846374.
   PubMed Web of Science ®Google Scholar
• Weissig V, Pettinger TK, Murdock N. 2014. Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine. 9:4357–4373. doi: 10.2147/IJN.S46900.
   PubMed Web of Science ®Google Scholar
• Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter CJH. 2013. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 65(1):315–499. doi: 10.1124/pr.112.005660.
   PubMed Web of Science ®Google Scholar
• Wu JX, Yang M, Berg F v d, Pajander J, Rades T, Rantanen J. 2011. Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability. Eur J Pharm Sci. 44(5):610–620. doi: 10.1016/j.ejps.2011.10.008.
   PubMed Web of Science ®Google Scholar
• Wyttenbach N, Kuentz M. 2017. Glass-forming ability of compounds in marketed amorphous drug products. Eur J Pharm Biopharm. 112:204–208. doi: 10.1016/j.ejpb.2016.11.031.
   PubMed Web of Science ®Google Scholar
• Xie T, Taylor LS. 2016a. Dissolution performance of high drug loading celecoxib amorphous solid dispersions formulated with polymer combinations. Pharm Res. 33(3):739–750. doi: 10.1007/s11095-015-1823-y.
   PubMed Web of Science ®Google Scholar
• Xie T, Taylor LS. 2016b. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives. Mol Pharm. 13(3):873–884. doi: 10.1021/acs.molpharmaceut.5b00798.
   PubMedGoogle Scholar
• Xie T, Taylor LS. 2017. Effect of temperature and moisture on the physical stability of binary and ternary amorphous solid dispersions of celecoxib. J Pharm Sci. 106(1):100–110. doi: 10.1016/j.xphs.2016.06.017.
   PubMed Web of Science ®Google Scholar
• Xiong X, Zhang M, Hou Q, Tang P, Suo Z, Zhu Y, Li H. 2019. Solid dispersions of telaprevir with improved solubility prepared by co-milling: formulation, physicochemical characterization, and cytotoxicity evaluation. Mater Sci Eng C Mater Biol Appl. 105:110012. doi: 10.1016/j.msec.2019.110012.
   PubMed Web of Science ®Google Scholar
• Xu H, Liu L, Li X, Ma J, Liu R, Wang S. 2019. Extended tacrolimus release via the combination of lipid-based solid dispersion and HPMC hydrogel matrix tablets. Asian J Pharm Sci. 14(4):445–454. doi: 10.1016/j.ajps.2018.08.001.
   PubMed Web of Science ®Google Scholar
• Yan T, Zhang Y, Ji M, Wang Z, Yan T. 2019. Preparation of irbesartan composite microparticles by supercritical aerosol solvent extraction system for dissolution enhancement. J Supercrit Fluids. 153:104594. doi: 10.1016/j.supflu.2019.104594.
   Web of Science ®Google Scholar
• Yang F, Su Y, Brown CD, DiNunzio J. 2021. Solubilizing temperature of crystalline drug in polymer carrier: A rheological investigation on a posaconazole-copovidone system with low drug load. Eur J Pharm Biopharm. 164:28–35. doi: 10.1016/j.ejpb.2021.04.015.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhao Y, Zhao Y, Ding Z, Fan Z, Zhang H, Liu M, Wang Z, Han J. 2018. Effect of HPMCAS on recrystallization inhibition of nimodipine solid dispersions prepared by hot-melt extrusion and dissolution enhancement of nimodipine tablets. Colloids Surf B Biointerfaces. 172:118–126. doi: 10.1016/j.colsurfb.2018.08.030.
   PubMed Web of Science ®Google Scholar
• Zi P, Zhang C, Ju C, Su Z, Bao Y, Gao J, Sun J, Lu J, Zhang C. 2019. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. Eur J Pharm Sci. 134:233–245. doi: 10.1016/j.ejps.2019.04.022.
   PubMed Web of Science ®Google Scholar